Lisata Therapeutics to Present at LD Micro Main Event XIX

Group 1 - Lisata Therapeutics will present a corporate overview at the LD Micro Main Event XIX Conference in San Diego from October 19-21, 2025 [1][3] - The presentation is scheduled for October 20th at 10:30 a.m. Pacific time, with opportunities for one-on-one meetings throughout the conference [2] - The LD Micro Main Event XIX will feature around 120 companies presenting and conducting private meetings with investors [3] Group 2 - Lisata Therapeutics is focused on developing innovative therapies for advanced solid tumors and other serious diseases, with its lead product candidate, certepetide, designed to enhance the targeting of anti-cancer drugs [4] - The company has established significant commercial and R&D partnerships based on its CendR Platform® technology and anticipates announcing multiple milestones over the next 1.5 years [4] - Lisata expects its projected capital to fund operations through the fourth quarter of 2026, including anticipated data milestones from ongoing and planned clinical trials [4]